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Abst rac t
Introduction: Specific immunotherapy has shown to be very useful for allergy control in dogs, with a common 
success rate ranging from 65% to 70%. However, this efficacy could probably be improved and the identification 
of individual allergomes, with the choice of more adequate molecular allergen pools for specific immunotherapy, 
being the strategy. 
Aim: To map Dermatophagoides pteronyssinus (Der p) allergens for mite-sensitized atopic dogs, for better under-
standing how individual allergograms may influence the response to house-dust mite immunotherapy.
Material and methods: To identify the Der p mite allergome for dogs, 20 individuals allergic to dust-mites and sen-
sitized to Der p, were selected. The extract from Der p was submitted to isoelectric focusing (IEF), one-dimensional 
(1-D) and two-dimensional (2-D) sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Separated 
proteins were blotted onto polyvinylidene difluoride (PVDF) membranes and immunoblottings were performed with 
patient sera. Allergen-bound specific IgE was detected.
Results: Eleven allergens were identified from isoelectric focusing (IEF), as well as from 1-D SDS PAGE. From 2-D 
SDS-PAGE, 24 spots were identified. 
Conclusions: Several similarities were found between dog and human allergograms and no absolute correlation 
between sensitization and allergy was observed either. As in humans, different individual allergograms do not seem 
to implicate different clinical patterns, but may influence the response to specific immunotherapy. The molecular 
epidemiology approach in veterinary allergy management, by the characterization of individual patients’ allergoms 
and by choosing the best molecular allergen pool for each patient could also improve the efficacy of allergy immu-
notherapy.
Key words: allergens, atopy, dog, house-dust mite, immunoblotting.
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Introduction
Allergen-specific immunotherapy, especially for 
aeroallergens, has proven to be useful for allergy control, 
promoting substantial clinical improvement in 65–75% 
of the cases [1] and should be prescribed as directed as 
possible [2, 3]. Nevertheless, those figures may be safely 
improved by using more accurate allergen pools for spe-
cific immunotherapy, which is already being studied for 
human allergy management [4–8].
Concerning mite allergens, the molecular epidemi-
ology concept may also lead to important innovations 
since the knowledge of mite allergen structure may allow 
a better interpretation of cross reactions between aller-
gens from different mite species. It may also lead us to 
a further explanatory molecular diagnosis and, therefore, 
to a more effective immunotherapy, based on patient 
IgE-recognized allergens [4]. Masuda et al. [9] had already 
performed several Immunodot and IgE-enzyme-linked 
immunosorbent assay (ELISA) inhibition studies, using 
Dermatophagoides pteronyssinus (Der p) and D. farinae 
(Der f) extracts and major allergens (Der p 1, Der p 2, 
Der f 1 and Der f 2), demonstrating important evidence of 
cross-reactivity between the two species and the useful-
ness of those methods for the diagnosis of IgE-mediated 
diseases in dogs. Regarding D. pteronyssinus, Asturias 
et al. [5] engineered two hybrid molecules (QM1 and QM2) 
derived from the two major allergens, Der p 1 and Der p 2, 
with less IgE-binding activity but preserved immunoge-
nicity. This strategy fulfilled the basic requirements of 
hypoallergenic molecules and showed suitability for the 
future specific immunotherapy of mite-allergic patients.
Recent studies performed by Kubota et al. [10] with 
Cryptomeria japonica pollen allergens, using sera from 
sensitized dogs with atopic dermatitis showed import-
ant differences in terms of individual allergen recognition 
between humans and dogs. In fact, a molecule that has 
shown to be a major allergen for humans may be a minor 
one for dogs and vice versa. Sometimes, an allergen for 
a given species may not be so for another. More recent-
ly, Ognjenovic et al. [11] reported several similarities and 
differences between dog and human sensitization to the 
Ambrosia artemisiifolia pollen, with 81% recognition of 
the 38 kDa band, belonging to the Amb a 1 group, be-
tween sensitized dogs. 
For a precise allergy diagnosis, or indication of al-
lergen-directed eviction measures [12], as well as to 
improve the efficacy of allergen-specific immunothera-
py [13], further fine tune laboratory information on the 
molecular diagnosis seems to be truly helpful. Other very 
important studies in this context have been performed, 
either characterizing major or minor Dermatophagoi-
des allergens for dogs with atopic dermatitis [14] or 
even characterizing and cloning D. farinae allergens like 
Der f 15 [15]. Another study by Raffan et al. [16] focus-
ing on the prevalence of the Dermatophagoides group 
1 allergens (Der p 1 and Der f 1) in homes with no dogs, 
healthy dogs and Dermatophagoides-sensitized atopic 
dogs, concluded that sensitization to D. farinae would 
result mainly from cross-reaction, because D. pteronys-
sinus was rather prevalent, while D. farinae was found 
to be rare.
Following very useful concepts, such as compo-
nent-resolved diagnosis and immunotherapy (CRD and 
CRIT) [17–19], while protein microarray systems are not 
available for veterinary proposals, characterization of pa-
tient serum IgE spectrotypes (individual allergograms) by 
immunoblotting techniques, with electrophoretic-sepa-
rated molecular allergens, may provide relevant informa-
tion, especially for immunotherapy decision [13].
Aim
In this work, the authors intended to further map 
D. pteronyssinus allergens for mite-sensitized atopic 
dogs, in order to start understanding how individual al-
lergograms may influence the response to house-dust 
mite immunotherapy.
Material and methods
Patient selection and characterization
At dermatology and allergy outpatient consultations, 
carried out at the University of Évora (Évora, Portugal) 
and at the RofCodina (Lugo, Spain) Veterinary Hospitals, 
all the patients were submitted to an extensive query 
for anamnestic and clinical parameters, in which they 
were selected by filling the clinical criteria defined by 
the International Task Force of Canine Atopic Dermatitis 
for atopy diagnosis [20]. For further selection, patients 
were submitted to intradermal testing (IDT) with D. pter-
onyssinus, D. farinae, Lepidoglyphus destructor, Acarus 
siro and Tyroglyphus putrescentiae extracts, and positive 
(histamine solution) and negative (solvent extract) con-
trols from Bial Aristegui (Bilbao, Spain). Specific IgE for 
a panel of the most common mites and pollens was also 
determined according to Lee et al. [21] (Univet, Barcelona, 
Spain). Twenty of those, mostly indoor patients and pre-
senting atopic dermatitis with perennial clinical manifes-
tations, which tested positive in the IDT and presented 
with specific IgE for D. pteronyssinus, were selected. Only 
1 patient (no. 2) was already undergoing mite-specific 
immunotherapy. 
Allergen extract preparation
Lyophilized D. pteronyssinus mites (Allergon, Angel-
holm, Sweden) were submitted to extraction by 2 h or-
bital stirring at 1 : 10 in 4ºC double-distilled water, for 
IEF, and in phosphate buffered saline (PBS) for SDS-PAGE. 
The extract was centrifuged at 3500 g for 10 min at 4ºC 
and supernatant protein concentration measured ac-
Postępy Dermatologii i Alergologii 2, April / 2015 
House-dust mite allergy: mapping of Dermatophagoides pteronyssinus allergens for dogs by two-dimensional immunoblotting
75
cording to the Warburg Christian Method [22] in a spec-
trophotometer (Beckman DU530 UV-VIS, Beckman 
Coulter, Brea, USA).
Protein separation
IEF
The D. pteronyssinus extract (protein concentration 
of 7.5 mg/ml) was subjected to IEF in 5% polyacrylamide 
gel (Acrylamide/Bisacrylamide from Bio-Rad, Hercules, 
USA) with a 12 : 1 mix of ampholytes from pH 4–6.5 and 
pH 3–10 (GE Healthcare, USA). Separated proteins were 
then blotted onto methanol-activated 0.2-µm-pore PVDF 
membranes (Bio-Rad) according to the technique de-
scribed by Martins et al. [23] for isoelectric-focused pro-
tein transference. The extract was also subjected to IEF, 
to produce 1-D gel strips for the 2-D gel electrophoresis.
SDS-PAGE
The D. pteronyssinus extract was treated with SDS, 
under non-reducing conditions, and submitted to 12% 
PAGE. Separated proteins were blotted under electro-
transference [24] onto methanol-activated 0.2-µm-pore 
PVDF membranes in a Trans-Blot Semi-Dry Transfer Cell 
(Bio-Rad). Two-dimensional separation was performed by 
12% SDS-PAGE of the 1-D IEF strips and separated pro-
teins were also blotted onto methanol-activated 0.2-µm-
pore PVDF membranes.
Antigen detection – immunoblotting
One-dimensional blotted membranes were cut in 
3-mm-wide strips, immersed for 2 × 0.5 h in blocking buf-
fer (1% non-fat dry milk – 0.1% Tween-20 in Tris-buffered 
saline, at pH 7.4) at room temperature and each strip 
was incubated overnight with individual patient sera, di-
luted at 1 : 10 in 1 ml blocking buffer. Eight patients (sera 
no. 1–6, 9 and 10) were tested with strips from IEF and 20 
(sera no. 1–20) with SDS-PAGE ones. One-dimensional im-
munoblots from IEF were also performed with 2 pools of 
4 sera, each (P1: sera no. 1, 3, 5 and 6, and P2: sera no. 2, 
3, 9 and 10), allowing to obtain spectrotypes as complex 
as possible, as those individuals, together, recognized 
allergens through a wide pH range. For sera no. 2, two 
samples were used: 2B (before immunotherapy) and 2A 
(after 1-year house-dust mite immunotherapy). After in-
cubation, strips were washed for 4 × 5 min in 0.9% NaCl 
– 0.1% Tween-20. For specific IgE detection, strips were 
incubated for 2 h with horseradish peroxidase-conjugat-
ed goat anti-dog-IgE antibody (Bethyl Laboratories, Inc., 
Montgomery, USA) at 1 : 1000 in blocking buffer, followed 
by 4 × 5 min washes in 0.9% NaCl – 0.1% Tween-20. An-
other 4 × 5 min washing cycle was carried out and spe-
cific IgE visualization performed by chromogenic reaction 
with 3.3’-diaminobenzidine/NiCl
2
 (Sigma-Aldrich, St. Lou-
is, USA) in Tris-buffered saline at pH 7.4.
Two-dimensional immunoblottings were performed 
by incubating blotting membranes with a pool of 15 pa-
tient sera, selected for their representative IgE-binding 
patterns in IEF or SDS-PAGE, diluted to 1 : 10 in 18 ml 
blocking buffer. Specific IgE was detected likewise with 
1-D strips.
Three controls were performed with 1-D strips: C1 – 
without serum; C2 – without serum or anti-dog IgE and 
C3 – with a pool of sera from 4 non-atopic dogs, negative 
for specific IgE to house-dust mites. Control for 2-D im-
munoblotting was performed with sera from 4 non-atop-
ic dogs, negative for specific IgE to house-dust mites.
To compare specificity of pattern recognition be-
tween secondary antibodies, 1-D IEF-separated strips 
were also submitted to immunoblotting with a four-pa-
tient pool of sera (no. 1, 3, 5 and 6) and incubated with 
mouse anti-dog-IgE biotin-labeled monoclonal antibody 
(AbDSerotec, Kidlington, UK) at 1 : 500 in blocking buf-
fer, followed by 4 × 5 min washes in 0.9% NaCl – 0.1% 
Tween-20 and 1 h incubation with ExtrAvidin-alka-
line phosphatase (Sigma-Aldrich) at 1 : 5000. Another 
4 × 5 min washing cycle was done and specific IgE vi-
sualization was performed by chromogenic reaction 
with nitrobluetetrazolium/5-bromo-4-chloro-3-indolyl 
phosphate (Sigma-Aldrich) in substrate buffer. Control 
was performed: C4 – with sera from 4 non-atopic dogs, 
negative for specific IgE to house-dust mites.
Results 
All patients presented with specific IgE and positive 
IDT, at least to D. pteronyssinus and D. farinae. Mean spe-
cific IgE to D. pteronyssinus was 357.8 ELISA absorbance 
units (EAU) (min. of 35 and max. of 967) with a standard 
deviation (SD) of 277.06. Mean IDT score was 1.8 (min. of 
1 and max. of 3) in a range from 1 to 4 with a SD of 0.68. 
From IEF separations, at least 11 allergens were iden-
tified from pI 5.4 to 6.8 (Figure 1 and Table 1). The mean 
number of recognized IEF allergen bands/patient was 6.25 
(min. of 3 and max. of 9) with a SD of 2.86. Although, other 
IgE-binding proteins, probably including several isoaller-
gens, were identified in P1 and P2 strips (Figure 1). From 
1-D SDS-PAGE, 11 allergen bands were also identified by 
patient sera. The mean number of recognized PAGE aller-
gen bands/patient was 5.33 (min. of 3 and max. of 8) with 
a SD of 1.55. Six allergen bands, with molecular weights 
(MW) close to 13.5, 23.5, 32.5, 47.5, 70 and 210–220 kDa 
showed major recognition (Figure 2 and Table 2). The ma-
jority of patients presented complex spectrotypes (Figures 
1 and 2). Two-dimensional separation disclosed multiple 
allergen spots from pI < 4.6 to > 6.9 and from 13.5 to 
210–220 kDa (Figure 3 A). A diagram of the 2-D identified 
allergome is shown in Figure 3 B, for a clearer representa-
tion. Controls, either using or not anti-dog IgE secondary 
antibodies, C1 and C2, respectively, did not show band 
recognition in blots. Controls with sera from non-atopic 
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patients, negative for specific IgE to house-dust mites (C3 
and C4) did not show recognition, either. No significant dif-
ference in specificity was found between the two anti-dog 
IgE systems tested. Patient no. 2, which has undergone 
1 year of mite-specific immunotherapy, increased the com-
plexity of the D. pteronyssinus spectrotype by the addition-
al recognition of a 28.5 kDa band (Figure 2 – Lanes 2 B and 
2 A, and Table 2), despite a clear clinical improvement. 
C – Controls, P – pools of sera, revealed with biotin-labeled mouse anti-dog-
IgE, App – sample application line.
Figure 1. Patient IgE immunoblots (patients/lanes no. 1–6, 9 
and 10) from IEF of Der p extract, revealed with horseradish 
peroxidase-conjugated goat anti-dog-IgE
App
pH
4.5
5.2
5.9
6.6
6.9
 2B 3 4 5 6 C3 C1 9 10 P1 P2 3 C4 1 3 1 3 C2
Table 1. Allergens recognized from Der p IEF
Patients Allergens (estimated pI* )
5.4 5.5 5.6 5.7 5.9 6.2 6.3 6.5 6.6 6.7 6.8
1 X X X    X X X  X
2B X      X X    
3 X  X X X  X X X X  
4  X X X  X X X X   
5 X X X   X X  X  X
6 X X X    X X X   
9 X X X X X  X X X X  
10 X X X X X  X X X X  
*Isoelectric point.
A significant positive correlation (r = 0.843) was veri-
fied between specific IgE to D. pteronyssinus and respec-
tive IDT scores, with a marked variability in individual 
specific IgE levels to D. pteronysinus (SD = 277.06) and 
a relatively low variation in individual IDT scores (SD = 
0.68). No significant correlation was found between spe-
cific IgE levels and the number of IEF allergen bands (r = 
0.189), and between IDT scores and the number of IEF 
allergens (r = 0.246). A moderate positive correlation was 
observed between specific IgE levels and the number of 
SDS PAGE allergens (r = 0.407), and between IDT scores 
and the number of SDS PAGE allergens (r = 0.431), while 
a negative one (r = –0.430) was found between the num-
ber of IEF and SDS PAGE allergens.
Discussion
No clear clinical differences were recognized among 
patients. Hence no specific IgE level, IDT score or pat-
tern of spectrotype was possible to relate to a specific 
clinical pattern. Nevertheless, IDT scores seemed to be 
a reliable parameter in terms of correspondence to the 
level of specific IgE to D. pteronyssinus. However, such 
high correlation may not occur between specific IgE lev-
els or IDT scores and the number of allergens observed 
from SDS PAGE.
Several similarities were found between dog and 
human D. pteronyssinus spectrotypes. Like humans [23], 
dogs also recognized pI 5.4, 5.5–5.7, 5.8–5.9 and 6.1–6.2, 
and 21.5–24.5, 28.5–29, 37, 58, 108.5–110 and 208–210 
kDa allergen bands. Another study performed by Le Mao 
et al. [25] with sera from mite-sensitized humans estab-
lished several important features about Der f allergens, 
associated to a close cross-reactive pattern with Der p, 
which was also confirmed by Masuda et al. [9]. In fact, 
the 24–25 kDa Der f1, with 10 isoforms from pI 5.9–8.2, 
may correspond to Der p1, represented here by the 23.5– 
27 kDa a, b, n, p and q spots, with pI < 4.6–6.6 (Figure 3 B). 
Der f2, with 14–15 kDa and 3 isoforms (pI 7.0, 7.2 and 
7.4) recognized by a monoclonal antibody against Der p2, 
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Table 2. Allergens recognized from Der p SDS-PAGE 1-D
Patients Allergens (estimated MW* [kDa])
13.5 23.5 28.5 32.5 35.5 37 47.5 58 70 110 210–220
1 X X  X  X X  X  X
2B  X  X   X  X X X
2A  X X X   X  X X X
3 X X  X  X X  X  X
4 X X  X    X X X X
5 X X  X X    X  X
6    X X X X    X
7 X X X X   X  X X X
8  X  X       X
9  X  X   X  X  X
10 X   X   X  X  X
11  X  X       X
12    X X      X
13       X X X X X
14 X X  X X    X  X
15    X     X  X
16  X   X      X
17 X X  X X  X  X  X
18 X X  X   X    X
19 X X  X   X  X  X
20  X  X X    X  X
*Molecular weight.
C – Controls, P – pools of sera, App – sample application line. 
Figure 2. Patient IgE immunoblots (patients/lanes no. 1-20) from SDS-PAGE of Der p extract, revealed with horseradish 
peroxidase-conjugated goat anti-dog-IgE
App
MW 
[kDa]
250
100
50
37
25
20
15
10
 7 8 3 2B 2A 9 10 11 12 13 4 5 6 14 15 16 17 18 19 20 C3 1 2 3 4 5 6 C1 C2
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may correspond to our 13.5 or 16.5 kDa spots, both with 
pI 4.7, probably Der p2. Der f1 immunodominant isoforms 
for humans, present pI 6.6–6.8, but for dogs only the 
23.5 kDa band (pI < 4.6 and 5.7 – spots a and n), proba-
bly Der p1, showed major recognition. Towards Der f2, pI 
6.9 and 7.2 bands were the immunodominant isoforms 
for humans, while for dogs, from the probable Der p 2 
bands, only the 13.5 kDa one (pI 4.7 – spot g) showed ma-
jor recognition. However, the 13.5 kDa band may also cor-
respond to Der p 5, an allergen close to Der f 5 (13–14 kDa 
with a pI 5.6 major isoform). Der f 3, a band close to 
30 kDa, with 4 isoforms (pI 4.9, 5.2, 5.3 and 5.9) for hu-
mans, which is possibly related to Der p 3, may correspond 
to the close to 28.5 kDa (pI 6.8 and > 6.9 – spots s and u) or 
to the 32.5 kDa (pI 6.9 – spot t) bands for dogs. Although, 
these 28.5 and 32.5 kDa dog IgE-recognized bands may 
Figure 3. A – IgE immunoblot with a pool of sera from 2-D Der p separation (dog Der p allergogram), revealed with horse-
radish peroxidase-conjugated goat anti-dog-IgE. B – Two-dimensional diagram from dog Der p allergogram in Figure 3 A, 
with the recognized spots identified from a to x
A
B
MW 
[kDa]
250
100
50
37
25
20
15
10
 4.6 5.2 5.9 6.6 6.9
MW 
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100
50
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 4.6 5.2 5.9 6.6 6.9
f
e
c d k
j
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o
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p q
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also correspond to Der p 7. In fact, the 28–31 kDa band 
(pI 6.4), also observed by Le Mao et al. [25], could be 
Der f 7 and despite a relevant recognition (90%) of the 
32.5 kDa band in our dog population, the level of each mo-
lecular allergen recognition between humans and dogs 
may diverge significantly [9]. Dogs also recognized a 58 kDa 
minor band (pI 5.4–6.5), close to the 58–60 kDa described 
band, with molecular and biological activities related to 
Der p 4 [25]. To proceed with the identification and cha-
racterization of D. pteronyssinus allergome for dogs, the 
selected population is being increased, several mite re-
combinant allergens with possible relevance for dogs, are 
being tested by inhibition assays and specific antibodies 
to molecular allergens will also be assessed.
As reported by Nuttall et al. [14], several high mo-
lecular weight allergens were also recognized by our 
mite-sensitized atopic population, with the 210–220 kDa 
band, probably the heavy chains of mite myosin, a mi-
nor allergen for humans [23], standing as the most 
recognized mite allergen in our dog-sensitized popula-
tion. Similarly to what happens for humans, with Der f 
allergens showing wide recognition through the high 
molecular weight (80–83 and 95–101 kDa) acidic range 
[25], important recognition was also observed for dogs 
through 110 and 210–220 kDa, at the acidic range (Fig-
ure 3 B – spots e, f and o). Those results closely follow 
Martins et al. [23] data for human Der p IgE-reactivity, 
where an intense recognition was also observed, with 
9 IgE-reactive bands through the pI 5.5–6.1 range.
The determination of individual spectrotypes, mainly 
2-D allergograms, has already shown great utility in the 
identification of implicated allergen molecules in human 
latex allergy, as demonstrated by Chardin and Peltre [12]. 
The interpretation of molecular allergen recognition may 
also be of great importance for an efficient immunother-
apy approach [13]. In the veterinary field, demonstration 
of relevant cross-reaction between Der p and Der f by 
Masuda et al. [9] perfectly matched the observations 
from Raffan et al. [16] that dog sensitization to Der f 
should be mainly due to cross-sensitization with Der p, 
which is more prevalent in the environment and also the 
primary sensitizing agent. These important observations 
suggest the interest of pursuing the identification of dif-
ferent mite species allergomes for dogs, which may be of 
considerable value for veterinary molecular epidemiology 
of allergy, by allowing rather specific and more effective 
immunotherapy. This is further exemplified by the ob-
servations of Willemse et al. [3], showing no difference 
in clinical efficiency between immunotherapy with Der f 
extract or with a placebo, probably because the verified 
sensitization to Der f resulted mostly from cross reaction 
with other primary sensitizing mite species, as reported 
by Raffan et al. [16]. In this case, a possible explanation 
could be that several sensitizing and clinically import-
ant allergens from other mite species, which were not 
cross-reactive with Der f, would stay out of the immuno-
therapy effect of the Der f extract, resulting in no clini-
cal benefit. Resch et al. [26] emphasized the importance 
of less frequent recognized allergens in humans, like 
Der p 10, the mite tropomyosin, when allergen-specific 
immunotherapy is considered, since patients were found 
suffering from clinically relevant house-dust-mite allergy, 
due to sensitization to Der p 10.
The usefulness of molecular epidemiology had also 
been defined by Bessot and Pauli [4], concerning mite 
allergy in humans, because it would lead to a better un-
derstanding of the cross reaction phenomena between 
different mite species, either from the same family or 
not. Further knowledge on this subject will probably open 
new perspectives regarding more specific immunothera-
py, based on genetically hypoallergenic variants of major 
allergens [4].
In our study, after a 1-year course of mite-specific im-
munotherapy, patient no. 2 showed a remarkable clinical 
improvement, but increased D. pteronyssinus spectrotype 
complexity, which could be associated with several Th2-
like immunological mechanisms, occurred in the initial 
phase of immunotherapy [27–29], suggesting no abso-
lute correlation between sensitization and allergy. In re-
cent studies carried out by our group, these observations 
were also made with other allergic patients, regarding 
different grass pollen spectrotypes, but so far it has not 
been possible to detect any correlation between those 
and the efficacy of immunotherapy (unpublished results). 
More patients should be studied to confirm any possible 
early/late evolution in sensitization during the course of 
specific immunotherapy.
Thereafter, deeper characterization of patients, espe-
cially in terms of sensitization to other mite species, with 
the identification of their allergomes and cross-reactive 
behavior by the inhibitionof ELISA and immunoblottings, 
will be needed, as it has been proven [9, 16]. The identi-
fication of mite molecular allergens for dogs, by specific 
antibodies, will also be crucial for a precise identification 
of the most relevant molecular allergens, allowing the 
necessary characterization of house-dust mite sensitiza-
tion and allergy, regarding a more successful immuno-
therapy.
As a future trend we think that the concept of CRD 
[18] and consequent CRIT [19] may also be applied to vet-
erinary allergology. In fact, CRD is already being applied 
to human allergy management through the Immune Sol-
id-phase Allergen Chip (ISAC – Thermo Fisher Scientific, 
USA) diagnostic facility. However, while these trade mark 
method is still not available for veterinary purpose, we 
consider that the identification and characterization of 
the most relevant allergens, especially for dogs, should 
continue through other available methods. For a better 
characterization of these identified allergens, further 
studies using several allergen-specific antibodies, recom-
binant allergens and mass spectrometry techniques are 
presently in the course.
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As for humans, studies of molecular epidemiology in 
dog allergy will allow clarifying the evolution of allergic 
response during immunotherapy. Hence, besides the 
very close clinical patterns between different patients, 
the individual pattern of sensitization for each allergenic 
source may also become of an outstanding relevance for 
the success of a real allergen-specific immunotherapy.
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